A surgeon's guide to anticoagulant and antiplatelet medications part one: Warfarin and new direct oral anticoagulant medications

10Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

Abstract

An increasing number of potent antiplatelet and anticoagulant medications are being used for the longterm management of cardiac, cerebrovascular, and peripheral vascular conditions. Management of these medications in the perioperative and peri-injury settings can be challenging for surgeons, mandating an understanding of these agents and the risks and benefits of various management strategies. In this two-part review, agents commonly encounter by surgeons in the perioperative and peri-injury settings are discussed and management strategies for patients on long-term antiplatelet and anticoagulant therapy reviewed. In part I, we review warfarin and the new direct oral anticoagulants. In part II, we review antiplatelet agents and assessment of platelet function and the perioperative management of long-term anticoagulant and antiplatelet therapy.

Cite

CITATION STYLE

APA

McBeth, P. B., Weinberg, J. A., Sarani, B., Yeung, L. Y. Y., & May, A. K. (2016). A surgeon’s guide to anticoagulant and antiplatelet medications part one: Warfarin and new direct oral anticoagulant medications. Trauma Surgery and Acute Care Open, 1(1). https://doi.org/10.1136/tsaco-2016-000020

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free